rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Instil Bio, Inc.

TIL · Nasdaq

Health CareBiotechnologyNot moving yet

TIL stood above a rising 150-day average in 0 of the last 52 weekly readings. It is 25.3% below that average now. Biotechnology: 18% of its 561 stocks in an uptrend (−9 points in four weeks); Health Care: 28% (−6 points in four weeks).

SEC filings

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 52
Industry in uptrend
18% -9 in 4 wk
Insider buys, 12 months
$0
Insider sales, 12 months
$0
Officials’ trades on record
0
Institutions holding
26 (-5)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 0 of 52 weeks.

23 Apr – 22 Oct
18%29%39%Apr 26Jun 26Jul 26Sep 26Oct 26

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$676K$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0
Sale orders, 12 months0
Buyers · sellers0 · 0

No open-market buy or sale by its insiders on record.

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders26-5 on the quarter
New · exited5 · 10
Reported value$29.2M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Curative Ventures V LLCunchanged · filed 31 Jul 20261,899,004$14.6M00.0%
BML Capital Management, LLCunchanged · filed 7 Aug 2026645,600$5.0M00.0%
Vivo Capital, LLCunchanged · filed 14 Aug 2026292,743$2.3M00.0%
UBS Group AGadded · filed 13 Aug 2026177,423$1.4M+171,045+2681.8%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026163,738$1.3M-10,845−6.2%
MILLENNIUM MANAGEMENT LLCadded · filed 14 Aug 2026134,575$1.0M+1,629+1.2%
Kalehua Capital Management LLCreduced · filed 14 Aug 202699,600$766K-40,249−28.8%
BlackRock, Inc.added · filed 7 Aug 202655,504$427K+3,486+6.7%
RENAISSANCE TECHNOLOGIES LLCreduced · filed 13 Aug 202650,300$387K-8,800−14.9%
NOMURA ASSET MANAGEMENT INTERNATIONAL INC.unchanged · filed 14 Aug 202650,000$385K00.0%
31 Mar 2023 – 30 Jun 2026
274052Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

George Matcham Company insiderDirector · last 11 Jun 20260 · 0
Gwendolyn Binder Company insiderDirector · last 11 Jun 20260 · 0
Neil W. Gibson Company insiderDirector · last 11 Jun 20260 · 0
R. Kent McGaughy Jr. Company insiderDirector · last 11 Jun 20261 · 0
Sandeep Laumas Company insiderCFO and CBO · last 10 Sep 20250 · 1
Bronson Crouch Company insiderCEO and Chairman · last 25 Apr 20251 · 0
Jack Nielsen Company insiderDirector · last 14 Jun 20231 · 0
Sumita Ray Company insiderChief Legal and Admin Officer · last 18 Jan 20230 · 0
Timothy L. Moore Company insiderChief Operating Officer · last 6 Sep 20220 · 0
Vijay Chiruvolu Company insiderChief Technical Officer · last 20 May 20220 · 0
Zachary Roberts Company insiderChief Medical Officer · last 4 Mar 20220 · 0
Curative Ventures V Llc Company insider10% owner · last 23 Mar 20211 · 0

Same industry

IOVA Iovance BiotherapeuticsLeading+124%
MRNA ModernaLeading+118%
ENTX Entera BioLeading+51%
ABCL AbCellera BiologicsLeading+50%
HALO Halozyme TherapeuticsLeading+47%
XNCR XencorLeading+44%
XERS Xeris Biopharma HoldingsLeading+42%
CPIX Cumberland PharmaceuticalsLeading+41%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Return on capital employedFY 2025 · to 31 Dec 2025-39.6%
Share count trendFY 2025 · to 25 Mar 20260.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$6.6M

Analyst forecasts

No analyst forecasts yet.